Nontuberculous mycobacteria

Česká verzia

Authors: I. Hricíková; M. Šterclová; M. Vašáková
Authors place of work: Primářka: doc. MUDr. Martina Vašáková, PhD. ; Fakultní Thomayerova nemocnice s poliklinikou, Praha ; Přednosta: prof. MUDr. Jiří Homolka, DrSc. ; Pneumologická klinika 1. LF UK
Published in the journal: Prakt. Lék. 2011; 91(3): 144-147
Category: Of different specialties

Summary

Nontuberculous mycobacteria (NTM) are currently more and more frequently identified as organisms causing diseases in human. The diseases caused by NTM are characterised by granulomatous inflammation involving in adult immunocompetent population mainly the lungs. The clinical picture comprises cough, sweats and weight loss. The crucial position in diagnosis and also in treatment of diseases caused by NTM is held by bacteriological investigation of sputum or material obtained by bronchoscopy or lung biopsy. The treatment of diseases caused by NTM is initiated in case of fulfilling all criteria for diagnosis, i.e. clinical signs, corresponding radiological picture and detection of NTM in investigated material. The long-term treatment is usually based on administration of combination of chemotherapeutics and antibiotics.

Key words:
nontuberculous mycobacteria, lung mycobacteriosis, diagnostic criteria, combined treatment.

Zdroje

1. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculosis mycobacteria. Am. J. Respi.r Crit. Care Med. 2 (Suppl.), S1-S25.

2. Aksamit, T. Mycobacterium avium complex pulmonary disease in patients with preexisting lung disease. Clin. Chest. Med. 2002, 23, p. 643-653.

3. Griffith, D., Aksamit, T., Brown-Elliot, A. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 2007, 175, p. 367-416.

4. Daley, C.l., Griffith, D. Pulmonary disease caused by rapidly growing mycobacteria. Clin. Chest. Med. 2002, 23, p. 623-632.

5. Chetchotisakd, P., Mootsikapun, P., Anunnatsiri, S. et al. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin. Infect. Dis. 2000, 30, p. 29-34.

6. Waller, E., Roy, A., Brumble, L. The expanding spectrum of mycobacterium avium complex-associated pulmonary disease. Chest 2006, 130, p. 1234-1243.

7. D’arienzo, P., Giampalma, E., Lavecchia, M. et al. Role of HRCT in the identification of atypical pulmonary mycobacteriosis. Radiol. Med. 2002, 103, p. 158-170.

8. Votava, M., Horváth, R., Denis, M. Polymerázová řetězová reakce v mikrobiologické diagnostice. Prakt. Lék. 2000, 11, s. 632-634.

9. Zatloukal, P., Fiala, P., Votruba, J. a kol. Pneumologie. Praha: Galén a Karolinum 2001, s. 107-109.

10. Hricíková, I., Šterclová, M., Bártů, V. Netuberkulózní plicní mykobakterióza - naše zkušenosti. Kazuistiky v alergologii, pneumologii a ORL, 2007, 4, s. 20-21.

11. Bártů, V. Diagnostika a léčba plicních mykobakterióz. Respirace 2003, 2, s. 36-39.

12. Griffith, D. Emergence of nontuberculous mycobacteria as pathogen in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2003, p. 810-812.